Viewing Study NCT06012695


Ignite Creation Date: 2025-12-24 @ 2:17 PM
Ignite Modification Date: 2026-01-11 @ 12:24 AM
Study NCT ID: NCT06012695
Status: RECRUITING
Last Update Posted: 2024-11-14
First Post: 2023-08-11
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: NBM-BMX Administered Orally to Patients with Solid Tumors or Newly Diagnosed Glioblastoma
Sponsor: Novelwise Pharmaceutical Corporation
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Malignant Neoplasm View
None Malignant Neoplasm of Brain View
Keywords: